A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

Clinical trial NCT02153398 · COMPLETED

Trial details

NCT number: NCT02153398
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastric Ulcer (GU)Duodenal Ulcer (DU)Anastomotic Ulcer (AU)Non-erosive Reflux Esophagitis Disease (NERD)Reflux Esophagitis (RE)Zollinger-Ellison Syndrome

Start date: 2014-06-01
Primary completion: 2016-04-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.